PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7896012-0	1995	Captopril increases skin microvascular blood flow secondary to bradykinin, nitric oxide, and prostaglandins.	Captopril	0-9	kininogen 1	Homo sapiens	63-73	
7896012-2	1995	This study was designed to test whether the ACEI captopril increases skin microvascular blood flow by a bradykinin-dependent mechanism.	Captopril	49-58	kininogen 1	Homo sapiens	104-114	
7896012-7	1995	The responses to bradykinin or captopril were abolished by coinjecting a bradykinin antagonist, a specific bradykinin B2 receptor antagonist, or inhibitors of NOS or cyclooxygenase.	Captopril	31-40	kininogen 1	Homo sapiens	73-83	
7896012-10	1995	The results indicate that captopril increases skin microvascular blood flow in rabbits and humans secondary to an increase in endogenous tissue bradykinin; this stimulates B2 receptors with subsequent release of prostaglandins and nitric oxide.	Captopril	26-35	kininogen 1	Homo sapiens	144-154